Human T-cell leukemia virus type 1 (HTLV-1), a human oncoretrovirus, is the etiologic agent of adult T-cell leukemia and of tropical spastic paraparesis/HTLV-1--associated myelopathy. Molecular epidemiologic studies have shown HTLV-1 proviruses to be remarkably stable genetically. The low levels of genetic drift in this virus have been used as a means for monitoring viral transmission and the movement of ancient human populations ([@R1],[@R2]). The few nucleotide substitutions observed in HTLV-1 strains are specific to the geographic origin of the patient and are unrelated to viral pathology ([@R1],[@R2]). Four major geographic HTLV-1 subtypes have been described: subtype A, cosmopolitan ([@R1],[@R2]); subtype B, central African; subtype C, Melanesian ([@R3]--[@R6]); and subtype D, present in central Africa, mainly in pygmies.

Previous reports have indicated that HTLV-1 is endemic in some remote or ancient populations in Melanesia ([@R3]--[@R14]). These populations include a small number of tribes from Papua New Guinea (especially the Hagahai people) ([@R5]) and some inhabitants of the Solomon Islands ([@R7]). Evidence of HTLV-1 infection has also been found in some aboriginal groups from Australia ([@R8]). Rare cases of adult T-cell leukemia and tropical spastic paraparesis/HTLV-1--associated myelopathy have also been described in these populations ([@R9]).

Genetic characterization of the few available Melanesian HTLV-1 strains has indicated that these HTLV-1 strains are the most divergent, constituting molecular subtype C (also called Melanesian subtype \[[@R3],[@R4], [@R6],[@R10]\]) in phylogenetic analyses. The discovery of such divergent variants has increased our understanding of the migration of HTLV-1--infected populations throughout the Pacific region. Furthermore, 1 of the calibration methods frequently used, in phylogenetic analyses, to estimate a time scale for the evolution of HTLV and simian T-cell leukemia virus (STLV) appears to coincide with the first human migrations to Melanesia and Australia 40,000--60,000 years ago ([@R2]).

We carried out a large serologic and molecular study to determine the prevalence of HTLV-1 and associated diseases in the Vanuatu Archipelago. Vanuatu, formerly known as the New Hebrides, is a Y-shaped archipelago made up of ≈80 islands. It is located in Melanesia, in the South Pacific region, northeast of Australia and south of the Solomon Islands. Vanuatu has a population of ≈200,000 inhabitants, most of whom (95%) are of Melanesian origin and are known as the Ni-Vanuatu.

ecade ago and were not based on stringent serologic criteria ([@R11]--[@R14]). No molecular characterization data are available for HTLV-1 from this area. The main goals of this study were to evaluate the situation concerning HTLV-1 infection in a remote Ni-Vanuatu population by using stringent serologic criteria for Western blotting and molecular characterization of the viruses.

The Study
=========

In February 2002, we recruited 391 women during a clinical survey for sexually transmitted diseases in various remote rural communities of western Ambae Island in the Penama Province of the Vanuatu Archipelago. Ambae Island, also known as Aoba, has a population of ≈9,500. The women participating in this survey were offered a complete clinical examination, with Papanicolaou test analysis for all women \>25 years of age. For each participant, we obtained plasma and buffy coats from 5 mL of blood obtained by venipuncture. The blood samples were rapidly transferred to Institut Pasteur de Nouvelle-Calédonie, where plasma and buffy coats were isolated, frozen, and stored (at --80°C) until HTLV screening. Informed consent was obtained from each woman participating in the field survey. This study was approved by the Ministry of Health of the Republic of Vanuatu and was supported by the Vanuatu Family Health Association, a local nongovernmental organization. Samples were taken from 391 women (mean age 36 years, range 16--82 years) with the following stratification by age: 11.2% from women 15--24 years of age, 28.4% from women 25--34 years of age, 31.2% from women 35--44 years of age, 17.4% from women 45--54 years of age, and 11.8% from women ≥55 years of age.

Plasma HTLV-1 antibodies were detected by enzyme-linked immunosorbent assay (ELISA) (HTLV-I+II, Abbott-Murex, Kent, United Kingdom) with Western blot (HTLV-I/II Blot 2.4, Diagnostic Biotechnology, Singapore) used for confirmation. On Western blot, plasma samples were considered HTLV-1--positive if they reacted to the 2 Gag proteins (p19 and p24) and both *env*-encoded glycoproteins: the HTLV-1--specific recombinant gp46-I peptide (MTA-1) and the specific HTLV-1/HTLV-2 recombinant GD 21 protein. Plasma samples were considered negative when no band were shown and indeterminate when partially reactive ([@R15],[@R16]).

Forty-nine of the 391 plasma samples studied tested positive or borderline by ELISA, and 4 of these samples displayed full reactivity on Western blot ([Figure 1](#F1){ref-type="fig"}). One sample also displayed a typical HTLV *gag*-indeterminate profile ([@R16]), and 6 displayed weak reactivity (19 or GD 21 bands). The 4 plasma samples testing positive by Western blot had higher immunofluorescence assay titers on MT2 (HTLV-1) cells than on C19 (HTLV-2) cells and high particle agglutination titers ([Table 1](#T1){ref-type="table"}). We carried out a second serologic survey on 64 members of the families of the 4 women seropositive for HTLV-1. This survey identified 2 more infected women; 1 was the mother of an index patient, and the other was the sister-in-law of another index patient ([Table 1](#T1){ref-type="table"}). These results confirm the circulation of HTLV-1 in this population.

![Representative seroreactivity pattern on Western blot that contains a recombinant GD 21 (common to human T-cell leukemia virus type 1 \[HTLV-1\] and HTLV-2) and 2 synthetic peptides specific for HTLV-1 (MTA-1) and HTLV-2 (K55). Lane 1, HTLV-1--positive control; lane 2, HTLV-2--positive control; lane 3, HTLV-1/2 negative control; lane 4--9, 6 plasma samples from the HTLV-1--positive women of Ambae Island displaying strong reactivity to GD 21 (faint band for VAN 251), to p19 and p24 (faint band for VAN 54), p26, p28, p32, p36 (faint bands for VAN 54 and AWM), and to MTA-1.](04-1015-F1){#F1}

###### Human T-cell leukemia virus type 1 (HTLV-1) antibody titers and molecular screening results for HTLV-1--seropositive women from Ambae Island, Vanuatu Archipelago\*

  Virus strain                         Age (y)   PA titers   IFA titers   WB pattern   PCR                
  ------------------------------------ --------- ----------- ------------ ------------ -------- ---- ---- ----
  VAN 54                               45        1/2,048     1/320        1/80         HTLV-I   \+   \+   \+
  VAN 136                              36        1/8,192     1/1,280      1/320        HTLV-I   \+   \+   \+
  VAN 251                              42        1/1,024     1/40         \<1/20       HTLV-I   \+   \+   \+
  VAN 335                              42        1/4,096     1/1,280      1/160        HTLV-I   \+   \+   \+
  DH1SIL2 (sister-in-law of VAN 335)   56        1/8,192     1/2,560      1/320        HTLV-I   NA   NA   NA
  AWM (mother of VAN 54)               63        1/1,024     1/160        1/40         HTLV-I   NA   NA   NA

\*PA, particle agglutination; IFA, immunofluorescence assay; WB, Western blot; PCR, polymerase chain reaction; LTR, long terminal repeat; NA, DNA not available.

High molecular-weight DNA was extracted from buffy coats from the 4 HTLV-1--seropositive women, 5 HTLV-1--seronegative persons, and 6 others with indeterminate Western blot results, by using the QIAamp DNA Blood Mini Kit (Qiagen GmbH, Hilden, Germany). The 15 DNA samples studied were subjected to polymerase chain reaction with primers specific for the human β-globin gene to check that cellular DNA was amplifiable for all samples ([@R17]). We then subjected DNA samples to 2 series of polymerase chain reaction to obtain the complete long terminal repeat (LTR) (755 bp) and a 522-bp region of the *env* gene as previously described ([@R18]). Fragments of the appropriate size were amplified for the 4 HTLV-1--seropositive women, whereas the other 11 samples yielded negative results. The amplified products were cloned and sequenced, and phylogenetic studies were performed as previously described ([@R18]). Both the complete LTR and the 522-bp *env* fragment were obtained for the 4 HTLV-1--seropositive women.

Conclusions
===========

The gp21 gene sequences of the 4 HTLV-1 strains involved were almost identical (99.6%--99.8 % nucleotide similarity) and were very similar to those of Melanesian strains. These strains were closely related (99.4%) to certain strains from Solomon Islanders (Mel 4, 8) but were only 97.1%--98.3% similar to strains from Papua New Guinea residents (Mel 2, 7) and from Australian aborigines (MSHR-1), respectively. Finally, the sequences of these new strains diverged from those of HTLV-1 strains from the 3 other main molecular subtypes (A, B, D) by 6% to 9%.

The 4 new HTLV-1 LTR sequences were also very closely related (98%--100% nucleotide similarity). They displayed 2% nucleotide divergence from Mel 5 (from a Solomon Islander), the only available LTR from all the HTLV-1 subtype C strains. However, they also displayed up to 11% nucleotide divergence from HTLV-1 strains from other molecular subtypes.

Phylogenetic analyses were performed on all the available *env* and LTR HTLV-1 sequences from Melanesia, and on several representatives of HTLV-1 and STLV-1 strains from the various subtypes/subgroups as described ([@R18]), by the neighbor-joining (NJ) method. Similar tree topologies were obtained for both genomic regions ([Figure 2](#F2){ref-type="fig"} and [Figure A1](#FA.1){ref-type="fig"}). Analyses of these trees confirmed that the 4 novel Vanuatu HTLV-1 strains were closely related to all available HTLV-1 subtype C strains ([Table 2](#T2){ref-type="table"}). Indeed, in the *env* analysis, which included 71 HTLV-1 strains (including 12 Melanesian strains and 1 from an Australian aborigine, [Table 2](#T2){ref-type="table"}) and 55 STLV-1 strains, the 4 new HTLV-1 strains clustered with subtype C ([Figure 2](#F2){ref-type="fig"}). This subtype only includes strains from Australia, Papua New Guinea, the Solomon Islands, and Vanuatu. Within this clade are at least 2 subgroups, strongly supported phylogenetically: 1 comprises the Vanuatu strains and most of the strains from the Solomon Islands (bootstrap values of 88%), and the other comprises the 3 isolates from Papua New Guinea (the Hagahai population), with a bootstrap value of 100%. Two other unique and divergent strains, the only strain available from an Australian aborigine (MSHR-1) and the other from a Solomon Islander (Mel-12), may represent prototypes of 2 other clades within the Melanesian subtype C.

![Unrooted phylogenetic tree generated by the neighbor-joining method by using the 522-bp fragment of the *env* gene. Distance matrices were generated with the DNADIST program, using the Kimura 2-parameter method and 5.65 as the transition/transversion ratio. Bootstrap analysis was carried out with 1,000 datasets. The values on the branches indicate frequencies of occurrence for 1,000 trees. The 4 new human T-cell leukemia virus type 1 (HTLV-1) sequences (VAN 54, VAN 136, VAN 251, VAN 335; GenBank accession nos. AY549879, AY549880, AY549881, AY549882) were analyzed with 126 HTLV-1/simian T-cell leukemia virus type 1 (STLV-1) sequences available from the GenBank database. The branch lengths are proportional to the evolutionary distance between the taxa.](04-1015-F2){#F2}

###### Epidemiologic data and GenBank accession numbers of the human T-cell leukemia virus type 1 (HTLV-1) strains of the Melanesian subtype C

  Country of origin   Age (y)   Sex   Birth         Residence        Clinical status   Virus name       *env* GenBank accession no.   LTR GenBank accession no.
  ------------------- --------- ----- ------------- ---------------- ----------------- ---------------- ----------------------------- ---------------------------
  Vanuatu             45        F     Ambae         Filakalaka       AC                HTLV-1 VAN 54    AY549879                      AY549875
                      36        F     Ambae         Ndui Ndui        AC                HTLV-1 VAN 136   AY549880                      AY549876
                      42        F     Ambae         Vinangwangwe     AC                HTLV-1 VAN 251   AY549881                      AY549877
                      42        F     Ambae         Lolobinanungwa   AC                HTLV-1 VAN 335   AY549882                      AY549878
  Papua New Guinea    21        M     Madang        Madang           AC                HTLV-1 MEL 1     L02533                        NA
                      60        F     Madang        Madang           AC                HTLV-1 MEL 2     M94197                        NA
                      31        M     Madang        Madang           AC                HTLV-1 MEL 7     U11576                        NA
  Solomon Islands     39        F     New Georgia   Guadalcanal      AC                HTLV-1 MEL 3     M94198                        NA
                      60        F     Guadalcanal   Guadalcanal      AC                HTLV-1 MEL 4     M94199                        NA
                      58        M     Guadalcanal   Guadalcanal      AC                HTLV-1 MEL 5     M94200                        L02534
                      38        M     Guadalcanal   Guadalcanal      TSP/HAM           HTLV-1 MEL 6     M93099                        NA
                      49        M     New Georgia   Guadalcanal      AC                HTLV-1 MEL 8     U11578                        NA
                      75        M     Rendova       Guadalcanal      AC                HTLV-1 MEL 9     U11580                        NA
                      13        F     Guadalcanal   Guadalcanal      AC                HTLV-1 MEL 10    U11566                        NA
                      42        F     Guadalcanal   Guadalcanal      AC                HTLV-1 MEL 11    U11568                        NA
                      60        F     Guadalcanal   Guadalcanal      AC                HTLV-1 MEL 12    U11570                        NA
  Australia           NA        NA    NA            NA               AC                HTLV-1 MSHR-1    M92818                        NA

\*LTR, long terminal repeat; F, female; M, male; AC, Asymptomatic carrier; TSP/HAM, tropical spastic paraparesis/HTLV-1--associated myelopathy; NA, not available.

In conclusion, we report, for the first time, the presence of HTLV-1 infection in a Ni-Vanuatu population living in remote villages. We also demonstrate that the viruses infecting these Ni-Vanuatu persons are novel HTLV-1 molecular variants belonging to the Melanesian divergent C subtype. This finding suggests that these viruses were introduced into Vanuatu by ancient migrations of Melanesian populations. The first people to reach Santa Cruz, Banks, Vanuatu, and the Loyalties Islands ≈3,600 years ago seem to have been Austronesian speakers ([@R19]). Epidemiologic and clinical surveys are under way in this area to determine the extent of such retroviral infection and associated neurologic and hematologic diseases. In addition, studies of viral and mitochondrial/nuclear DNA are being conducted and should provide insight into the migrations of the first settlers and the origin, evolution, and modes of dissemination of such retroviruses.
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![Unrooted phylogenetic tree generated by the neighbor-joining method by using the complete fragment of the long terminal repeat (LTR) (755 bp). Distance matrices were generated with the DNADIST program, using the Kimura 2-parameter method and 5.17 as the transition/transversion ratio. Bootstrap analysis was carried out with 1,000 datasets. The values on the branches indicate frequencies of occurrence for 1,000 trees. The 4 new human T-cell leukemia virus type 1 (HTLV-1) sequences (VAN 54, VAN 136, VAN 251, VAN 335; GenBank Accession nos. AY549875, AY549876, AY549877, AY549878) were analyzed with 75 HTLV-1/STLV-1 sequences available from the GenBank database. The branch lengths are proportional to the evolutionary distance between the taxa.](04-1015-FA1){#FA.1}
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